64 completed, 3 recruiting, 3 unknown, 2 not yet recruiting. 28 Phase 4, 20 Phase 3, 12 Phase 1, 10 Phase 2, 4 Not applicable.
Follow levocetirizine: new trials by email Literature Review of levocetirizine trials Research Report on levocetirizine
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Steroid Use in Treatment of Allergic Reactions to Food Antihistamines, Systemic corticosteroids, Adrenaline (rescue medication) - Anaphylactic Reaction, Anaphylaxis | Phase 4 | Recruiting | Johannes Trueck | 160 | 2026-01-26 | 2026-01-27 |
| Efficacy of Bilastine Up-dosing (40 mg ) Versus Combination of Bilastine (20 mg )With Levocitirizine (5 mg) in the Treatment of Chronic Spontaneous Urticaria tab bilastine 20 mg, tab bilastine 20 mg + tab levocetrizine 5 mg - Chronic Spontaneous Urticaria (CSU) | Not applicable | Completed | Derma Techno Pakistan | 60 | 2025-08-18 | 2026-01-26 |
| A Trial of Camrelizumab Plus Nab-paclitaxel and Levocetirizine in Metastatic or Recurrent TNBC Camrelizumab, Nab paclitaxel, Levocetirizine Hydrochloride - Breast Cancer | Phase 2 | Not yet recruiting | Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University | 60 | 2025-04-01 | 2025-03-26 |
| Treatment Options for Chronic Urticaria Autologous serum therapy, Oral levocetirizine - Chronic Urticaria | Phase 2 | Not yet recruiting | Sheikh Zayed Medical College | 72 | 2025-02-01 | 2025-02-10 |
| Exploring Novel Therapeutic Approaches for Disorders of Gut-Liver-Brain Interaction-H1/H2 Famotidine, Levocetirizine, Fuyuan Gasmin - Functional Gastrointestinal Disorders | Phase 2 | Recruiting | Buddhist Tzu Chi General Hospital | 45 | 2025-01-01 | 2026-10-05 |
| Clinical Study to Evaluate the Possible Efficacy and Safety of Levocetirizine in Patients With Diabetic Kidney Disease Valsartan 80 mg, Empagliflozin 10 MG, Levocetirizine - Diabetic Nephropathies | Phase 2 | Completed | Mostafa Bahaa | 60 | 2022-12-20 | 2026-03-31 |
| A Phase I Study of LY3471851 in Healthy Participants LY3471851, Placebo, Levocetirizine - Healthy | Phase 1 | Completed | Nektar Therapeutics | 41 | 2022-10-05 | 2023-11-18 |
| A Histamine Pharmacodynamic Biomarker to Guide Treatment in Pediatric Asthma (HAS3) Levocetirizine Dihydrochloride, Placebo - Allergic Asthma | Phase 3 | Completed | Bridgette Jones | 55 | 2021-04-28 | 2026-07-01 |
| Comparison of the Effects for Lightening the Shiners Among Different Treatments for Rhinitis Oral Levocetirizine, Combined Intranasal Mometasone Furoate with oral Levocetirizine, Combined Intranasal Mometasone Furoate with oral Levocetirizine plus intranasal Oxymetazoline - Allergic Rhinitis, Vasomotor Rhinitis | Not applicable | Recruiting | Camillians Saint Mary's Hospital Luodong | 450 | 2020-06-16 | 2022-04-27 |
| Influence of H1-antihistamines on the Dermal Blood Flow Response to Histamine, Cinnamaldehyde and Capsaicin. Desloratadine Single Dose, Levocetirizine Single Dose, Desloratadine Fourfold Dose - Pruritus | Not applicable | Completed | Universitaire Ziekenhuizen KU Leuven | 12 | 2019-10-28 | 2020-05-27 |
| COrticosteroids in acUte uRticAria in emerGency dEpartment Placebo Oral Tablet, Cortancyl Oral Tablet, Levocetirizine Oral Tablet - Urticaria, Angiœdema | Phase 3 | Completed | Assistance Publique - Hôpitaux de Paris | 137 | 2019-09-21 | 2025-09-22 |
| A Trial to Evaluate the Effect of Vitamin D Supplementation in Patients With Chronic Urticaria Vit D - Urticaria, Vitamin D Deficiency | Phase 4 | Unknown | Post Graduate Institute of Medical Education and Research, Chandigarh | 262 | 2019-06-21 | 2019-06-24 |
| Efficacy and Cost Analysis of Steroids in Treatment of Otitis Media With Effusion Mometasone 50 Mcg/Inh Nasal Spray, Antibiotics + Antihistamine (levocetirizine) + Nasal decongestants (Oxymetazoline 0.025%), Steroid Drug (prednisolone) - Otitis Media With Effusion | Phase 4 | Completed | Lumbini Medical College | 160 | 2018-09-05 | 2020-06-19 |
| PK and Safety Study of HCP1102, HGP0813 and HGP1408 montelukast and levocetirizine FDC, Singulair + xyzal - Healthy | Phase 1 | Completed | Hanmi Pharmaceutical Company Limited | 24 | 2017-07-19 | 2017-12-13 |
| To Assess and Compare the Efficacy of Cyclosporine Versus Azathioprine in the Treatment of Chronic Refractory Urticaria cyclosporine vs azathioprine - Chronic Refractory Urticaria | Phase 1 / Phase 2 | Completed | Post Graduate Institute of Medical Education and Research, Chandigarh | 56 | 2016-12-06 | 2018-01-11 |
| Efficacy of Levocetirizine Fourfold Dosage in Chronic Spontaneous Urticaria Levocetirizine (as levocetirizine dihydrochloride), 5mg ( then 20 mg) per day . Oral administration., Levocetirizine, (as levocetirizine dihydrochloride) 20 mg ( then 5 mg) per day. Oral administration. - Chronic Spontaneous Urticaria | Phase 3 | Completed | Hospices Civils de Lyon | 15 | 2015-07-01 | 2018-09-18 |
| Montelukast and Fexofenadine Versus Montelukast and Levocetrizine Combination in Allergic Rhinitis Montelukast, Fexofenadine, Levocetrizine - Allergic Rhinitis | Phase 4 | Completed | Indira Gandhi Medical College, Shimla | 70 | 2014-04-01 | 2015-09-16 |
| Levocetirizine + Capecitabine + Bevacizumab for Patients With Refractory Colorectal Cancer Bevacizumab, Capecitabine, Levocetirizine - Colorectal Neoplasms | Phase 2 | Completed | Washington University School of Medicine | 47 | 2013-04-01 | 2017-04-20 |
| Study to Evaluate the Pharmacokinetics and Safety of Singulair and Xyzal in Free Combination and Fixed-dose Combination HCP1102, Singulair and Xyzal - Rhinitis | Phase 1 | Completed | Hanmi Pharmaceutical Company Limited | 28 | 2012-07-01 | 2013-08-13 |
| Efficacy and Safety of Concomitant Montelukast Sodium and Levocetirizine Dihydrochloride in Perennial Allergic Rhinitis (PAR) Patients Montelukast + Levocetirizine, Levocetirizine, Montelukast - Perennial Allergic Rhinitis | Phase 3 | Completed | Hanmi Pharmaceutical Company Limited | 283 | 2012-06-01 | 2013-04-08 |
Showing 20 of 74. Sign in to see all of them.
Rhinitis, Allergic (14) · Rhinitis (12) · Chronic Urticaria (10) · Rhinitis, Allergic, Seasonal (10) · Urticaria (8) · Rhinitis, Allergic, Perennial (6) · Pruritus (5) · Hypersensitivity (4) · Asthma (3) · Rhinorrhea (3) · Sneezing (3) · Dermatitis (2) · Dermatitis, Atopic (2) · Nasal Obstruction (2) · Rhinitis, Vasomotor (2)
UCB Pharma (22) · Hanmi Pharmaceutical Company Limited (5) · GlaxoSmithKline (4) · Dr. Reddy's Laboratories Limited (2) · IPCA Laboratories Ltd. (2) · Institut für Atemwegsforschung GmbH (2) · Organon and Co (2) · Post Graduate Institute of Medical Education and Research, Chandigarh (2) · UCB S.A. - Pharma Sector (2) · AAADRS Clinical Research Center (1) · Assistance Publique - Hôpitaux de Paris (1) · Association Asthma, Bulgaria (1) · Brian J Lipworth (1) · Bridgette Jones (1) · Buddhist Tzu Chi General Hospital (1)
United States (12) · South Korea (7) · Germany (6) · India (6) · France (5) · Belgium (4) · Canada (3) · Italy (3) · Japan (3) · Spain (3) · Taiwan (3) · United Kingdom (3) · Pakistan (2) · Poland (2) · Romania (2)
Claus Bachert, MD, PhD (2) · Dr. Rupesh Vala, M.B.B.S. (2) · Sudershan Vishwanath, MD (2) · Arun Nair, MRCP (1) · Bridgette L. Jones, MD (1) · Cheng-Tsung Yang (1) · Davinder Parsad, MD (1) · Douglas B Tzanetos, M.D. (1)
PMID 20819318, PMID 10606940, PMID 11707753, PMID 1197147, PMID 13766957, PMID 15339201, PMID 15878456, PMID 15966463, PMID 16490466, PMID 16719251, PMID 18814452, PMID 19187327, PMID 19281911, PMID 19860762, PMID 20350147, PMID 20377116, PMID 23147964, PMID 25629743, PMID 25644617, PMID 26740893, PMID 26760413, PMID 27115216, PMID 27536452, PMID 28602936, PMID 29438602, PMID 30215894, PMID 30239057, PMID 31179187, PMID 31439599, PMID 31690374, PMID 32271144, PMID 38088821, PMID 40946347, PMID 5926923, PMID 8120268, PMID 9031796, PMID 9500748
2004 (2), 2015 (1), R01HD100545 (1)